Article citationsMore >>

Maron MS, Olivotto I, Zenovich AG, et al. Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction. Circulation. 2006; 114(21): 2232-2239.

has been cited by the following article:

Article

A Rare form of Hypertrophic Cardiomyopathy with Mid-cavity Obstruction

1Department of Medicine, Poplar Bluff Regional Medical Center, Poplar Bluff, Missouri, USA

2Cardiovascular Institute of Southern Missouri, Poplar Bluff Regional Medical Center, Poplar Bluff, Missouri, USA


American Journal of Medical Case Reports. 2022, Vol. 10 No. 9, 239-243
DOI: 10.12691/ajmcr-10-9-7
Copyright © 2022 Science and Education Publishing

Cite this paper:
Muhammad Shabbir Ijaz, H.K. Reddy. A Rare form of Hypertrophic Cardiomyopathy with Mid-cavity Obstruction. American Journal of Medical Case Reports. 2022; 10(9):239-243. doi: 10.12691/ajmcr-10-9-7.

Correspondence to: H.K.  Reddy, Cardiovascular Institute of Southern Missouri, Poplar Bluff Regional Medical Center, Poplar Bluff, Missouri, USA. Email: m.shabbir.ijaz.md@gmail.com

Abstract

Hypertrophic cardiomyopathy (HCM) is a genetic disorder of cardiac myocytes with variable penetrance and heterogenous phenotypic expression leading to different morphologies of left ventricular (LV) hypertrophy which are usually associated with dynamic left ventricular outflow tract (LVOT) obstruction. Up to 2 percent of cases of HCM have a morphology of mid-cavity or mid-ventricular obstruction in which LV cavity is divided into two cavities by apposition of the hypertrophied septum and free wall, and is many times associated with pressure gradients between both cavities usually in the range of 50-70 mmHg but as high as 110 mmHg has been reported (3). We present a case of this rare form of mid-cavity obstruction with an exceptionally high intraventricular pressure gradient of 154 mmHg and apical aneurysm formation.

Keywords